Figure 3.

PFS analysis in subgroups. Largest sample size ≥5 cm was correlated with decreased PFS in HCC patients (E). Number of nodules ≥2 and BCLC stage B/C were numerically associated with shorter PFS (D, G). No correlation of PFS with age (A), gender (B), relapsed/de novo (C), Child‐Pugh stage (F), cycles of DEB‐TACE (H), and AFP level (I) was observed. Survival analysis was performed using Kaplan‐Meier method and determined by the Log‐rank test. PFS, progression‐free survival; HCC, hepatocellular carcinoma; BCLC, Barcelona Clinic Liver Cancer; DEB‐TACE, drug‐eluting beads‐transarterial chemoembolization; AFP, alpha‐fetoprotein